Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial to Evaluate Blood and Imaging Based Biomarkers for Aromatase Inhibitor Induced Musculoskeletal Syndrome

NCT03665077 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT03665077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03665077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial to Evaluate Blood and Imaging Based Biomarkers for Aromatase Inhibitor Induced Musculoskeletal Syndrome
Lead sponsor
University of Arizona
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2018
Completion date
June 15, 2022
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aromatase inhibitor induced musculoskeletal syndrome (aimss), breast cancer